| Name | Title | Contact Details |
|---|
Headquartered near Zurich, Switzerland, Phonak, a member of the Sonova Group, was born in 1947 from a passion and dedication to take on the most difficult hearing challenges. As the industry`s leading provider, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people`s lives to thrive socially and emotionally. We believe in changing lives and creating a world where `Life is on` for everyone.
Engage with your audience through hand sanitizing billboards. Terraboost Media has established a network of 52,000 boards throughout the top 130 DMAs in supermarkets, drug stores, shopping malls and airports reaching an audience of over 1.4 billion per month. Brands can literally engage with their audience with a dose of wellness and by selecting the vertical networks and/or zip codes, counties that matter. QR codes, brochures, business reply cards and coupons provide advertisers with means of tracking. Join the over 180 satisfied repeat brands who continue to leverage this engaging media platform of which Arbitron research confirms 63% ad recall and 93% positive brand opinion, along with a 30% lift in purchase intent.
Sterigenics International is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Tri-State Surgical Supply and Equipment is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.